These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34979022)

  • 1. Letter to the Editor From Jialal: "Higher Incidence of Metabolic Syndrome in Black Women With Polycystic Ovary Syndrome: A Longitudinal Study".
    Jialal I
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e2198-e2199. PubMed ID: 34979022
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to Letter to the Editor From Jialal: "Higher Incidence of Metabolic Syndrome in Black Women With Polycystic Ovary Disease: A Longitudinal Study".
    Lee I; Dokras A
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e2210. PubMed ID: 34979554
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolic inflexibility in women with polycystic ovary syndrome: a systematic review.
    Rimmer M; Tan BK; Teede H; Thangaratinam S; H Al Wattar B
    Gynecol Endocrinol; 2020 Jun; 36(6):501-507. PubMed ID: 31793357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and contributions of hyperandrogenism to insulin resistance and other metabolic profiles in polycystic ovary syndrome.
    Huang R; Zheng J; Li S; Tao T; Ma J; Liu W
    Acta Obstet Gynecol Scand; 2015 May; 94(5):494-500. PubMed ID: 25711494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex hormone-binding globulin, oligomenorrhea, polycystic ovary syndrome, and childhood insulin at age 14 years predict metabolic syndrome and class III obesity at age 24 years.
    Glueck CJ; Morrison JA; Daniels S; Wang P; Stroop D
    J Pediatr; 2011 Aug; 159(2):308-13.e2. PubMed ID: 21362574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional study.
    Chan JL; Kar S; Vanky E; Morin-Papunen L; Piltonen T; Puurunen J; Tapanainen JS; Maciel GAR; Hayashida SAY; Soares JM; Baracat EC; Mellembakken JR; Dokras A
    Am J Obstet Gynecol; 2017 Aug; 217(2):189.e1-189.e8. PubMed ID: 28400308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran.
    Tehrani FR; Rashidi H; Khomami MB; Tohidi M; Azizi F
    Reprod Biol Endocrinol; 2014 Sep; 12():89. PubMed ID: 25224635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycystic ovary syndrome and metabolic syndrome.
    Ali AT
    Ceska Gynekol; 2015 Aug; 80(4):279-89. PubMed ID: 26265416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher Incidence of Metabolic Syndrome in Black Women With Polycystic Ovary Syndrome: A Longitudinal Study.
    Lee I; Vresilovic J; Irfan M; Gallop R; Dokras A
    J Clin Endocrinol Metab; 2022 Mar; 107(4):e1558-e1567. PubMed ID: 34928388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies.
    Sanchez-Garrido MA; Tena-Sempere M
    Mol Metab; 2020 May; 35():100937. PubMed ID: 32244180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals.
    Becerra-Fernández A; Pérez-López G; Román MM; Martín-Lazaro JF; Lucio Pérez MJ; Asenjo Araque N; Rodríguez-Molina JM; Berrocal Sertucha MC; Aguilar Vilas MV
    Endocrinol Nutr; 2014; 61(7):351-8. PubMed ID: 24680383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contribution of hyperandrogenism to the development of metabolic syndrome in obese women with polycystic ovary syndrome].
    Rehme MF; Pontes AG; Corrente JE; Franco JG; Pontes A
    Rev Bras Ginecol Obstet; 2013 Dec; 35(12):562-8. PubMed ID: 24500511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome and insulin resistance in Thai women with polycystic ovary syndrome.
    Pantasri T; Vutyavanich T; Sreshthaputra O; Srisupundit K; Piromlertamorn W
    J Med Assoc Thai; 2010 Apr; 93(4):406-12. PubMed ID: 20462081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hyperandrogenism on metabolic abnormalities in patients with polycystic ovary syndrome: a meta-analysis.
    Yang R; Yang S; Li R; Liu P; Qiao J; Zhang Y
    Reprod Biol Endocrinol; 2016 Oct; 14(1):67. PubMed ID: 27756332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethnicity in polycystic ovary syndrome.
    Shah D; Rasool S
    Climacteric; 2023 Feb; 26(1):15-20. PubMed ID: 36459492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome and its components in different phenotypes of polycystic ovary syndrome.
    Krentowska A; Kowalska I
    Diabetes Metab Res Rev; 2022 Jan; 38(1):e3464. PubMed ID: 33988288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycystic ovary syndrome and the risk of cardiometabolic complications in longitudinal studies.
    Jacewicz-Święcka M; Kowalska I
    Diabetes Metab Res Rev; 2018 Nov; 34(8):e3054. PubMed ID: 30089337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of ovulation in infertile women with hyperandrogenism and insulin resistance.
    Barbieri RL
    Am J Obstet Gynecol; 2000 Dec; 183(6):1412-8. PubMed ID: 11120504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Apolipoprotein B/A1 Ratio is Associated With Metabolic Syndrome Components, Insulin Resistance, Androgen Hormones, and Liver Enzymes in Women With Polycystic Ovary Syndrome.
    He H; Feng J; Zhang S; Wang Y; Li J; Gao J; Cong J; Gong Y; Wu X
    Front Endocrinol (Lausanne); 2021; 12():773781. PubMed ID: 35069437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome.
    Moghetti P; Tosi F; Bonin C; Di Sarra D; Fiers T; Kaufman JM; Giagulli VA; Signori C; Zambotti F; Dall'Alda M; Spiazzi G; Zanolin ME; Bonora E
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E628-37. PubMed ID: 23476073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.